Moderna hantavirus vaccine enters Phase 1 trials by 2026-12-31

Moderna’s hantavirus vaccine development is in early stages. Given the recent surge in stock price and urgency from public health concerns, accelerated trials are likely.

Implied probability (Yes)

70%